FDA Grants Second Approval under the National Priority Voucher Pilot Program - fda.gov
Source:FDA.gov
The U.S. Food and Drug Administration today issued an approval for the lung cancer drug Hernexeos (zongertinib) as a part of the new Commissioner’s National Priority Voucher (CNPV) pilot program.
Related Articles
$10 Million to Advance AI By and For People - MacArthur Foundation
Bitcoin Falls Below $70,000 as Crypto Crisis Gets Scary - Barron's
Stock Market Today: Dow Closes At Another Record High; Nasdaq Breaks Win Streak (Live Coverage) - Investor's Business Daily
Stock Market Today: The Dow Jones index led the major indexes with a gain on Tuesday after a day of …
Fiery Democrats attack Trump over shocking new report: ‘This is a tax on you’ - NJ.com
The report from the nonpartisan Tax Foundation found that U.S. households had a tax increase of …